Virology Research Services Ltd

What Virology Research Services Ltd does

Virology Research Services Ltd (VRS) is a UK-based, privately held contract research organization founded in 2017 and headquartered at Kent Science Park, Sittingbourne. Operating from purpose-built CL2 and CL3 containment laboratories, the company provides bespoke virology research services to pharmaceutical and biotechnology firms, academic researchers, and industrial product manufacturers. Core capabilities include antiviral drug screening with high-content and high-throughput imaging (CellInsight CX5, Opera Phoenix), Air-Liquid Interface (ALI) cell culture and 3D bronchial organoid models using primary human bronchial epithelial cells, virus detection and quantification assays (TCID50, plaque/immunofocus, qPCR), and immunogenicity assays (neutralization, antibody-dependent enhancement, ELISA). VRS also offers ISO/IEC 17025-accredited industrial antiviral testing against ISO 21702, ISO 18184, DIN EN 14476, ASTM E1052, and ASTM E1053 standards for manufacturers of antimicrobial surfaces, textiles, and disinfectants.

The company generates revenue through three streams: (1) project-based contract research services quoted per scope, priced on a professional-services basis; (2) branded products, specifically the Detect Pro Influenza A and B Real-Time PCR Detection Kits launched in 2024 at £250 per 100-reaction kit, representing its first expansion from services into products; and (3) educational content, including the Neutralisation Assay training course with optional £80 certification. The go-to-market is direct B2B engagement with senior scientist consultation offered free at intake, supported by content marketing via blog, newsletter (VRSLetter), social channels, and free online virology calculators. VRS holds ISO/IEC 17025:2017 (Perry Johnson Laboratory Accreditation Inc.) and ISO 9001:2015 certifications, and in October 2025 entered a strategic partnership with Advanced Virology Inc. to bundle engineered virus production with its testing services. Named customers include Eli Lilly, Roche Diagnostic Solutions, LGC Group (The Native Antigen Company), Sanitized AG, Excivion, CycloLabs, and UCL Drug Discovery Group.

Name

Virology Research Services Ltd

Legal name

Virology Research Services Ltd

Website

https://virologyresearchservices.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Virology Research Services Ltd is a UK-based contract research organization offering bespoke virology services — antiviral drug screening, ALI/organoid respiratory models, immunogenicity assays, and ISO-accredited industrial antiviral testing — to pharmaceutical, biotech, academic, and industrial clients from its CL2/CL3 labs at Kent Science Park.

Ownership category

akta.pro rank

Product category

Contract Research Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

akta.pro secondary industries

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

Keywords

• Contract virology research
• Antiviral drug screening
• Industrial antiviral testing
• Respiratory virus assays
• High-containment laboratory services

Headquarters

HQ city

Sittingbourne

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Research Services (CRO): Experimental virology research services provided to pharmaceutical, biotechnology companies, and academic researchers. Services include antiviral drug screening, virus detection/quantification, mode-of-action studies, immunogenicity assays, and bespoke research projects. Revenue generated through project-based contracts with customized pricing.
2. Detection Kit Products: Sale of virology detection products including Detect Pro Influenza A and B Real-Time PCR Detection Kits at £250 per kit (100 reactions). PRO product line developed from internal laboratory needs.
3. Training Courses: Educational courses such as the Neutralisation Assay course providing theoretical and practical frameworks for scientists. Optional certification available for £80.
4. Industrial Antiviral Testing: ISO-accredited testing services for industrial clients testing antiviral properties of surfaces, textiles, and disinfectants against various viruses.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Virology Research Services Ltd is a UK-based contract research organization offering bespoke experimental virology research and ISO-accredited antiviral testing from CL2 and CL3 containment laboratories at Kent Science Park. Services include industrial antiviral testing (ISO 21702, ISO 18184, DIN EN 14476, ASTM standards), antiviral drug screening, ALI and 3D bronchial organoid airway models, virus titration (TCID50, plaque/immunofocus), qPCR-based detection, neutralization and ADE assays, ELISA, and high-throughput compound screening. VRS also sells its own Detect Pro Influenza A and B Real-Time PCR Detection Kits and offers an online Neutralisation Assay training course.

Product overview

Virology Research Services Ltd operates as a consultancy and experimental service provider offering a portfolio of virology research services alongside a nascent product line (Detect Pro). The services business provides industrial antiviral testing (ISO 21702, ISO 18184, suspension tests, and standards such as DIN EN 14476, ASTM E1052, ASTM E1053), antiviral drug screening with high-content imaging, Air-Liquid Interface (ALI) and bronchial organoid 3D cell culture models, virus detection and quantification services (TCID50, plaque/immunofocus assays, qPCR), immunogenicity and antibody efficacy assays (neutralization, ADE, ELISA), and high-throughput screening. The recently launched Detect Pro product range includes two SYBR Green-based real-time RT-PCR detection kits for Influenza A and Influenza B (100 reactions each, £250), representing the company's expansion into products alongside its core services business. VRS also offers a neutralization assay training course. Together, the services and products are designed to support the full drug, vaccine, and diagnostic discovery pipeline from early-stage research through regulatory testing.

Differentiator

Problem solved

Functional benefit

Brands

• Detect Pro: Product line of virus detection kits including Influenza A and B Real-Time PCR Detection Kits

Products and services

• Detect Pro Influenza A Real-Time PCR Detection Kit SYBR Green-based real-time RT-PCR kit for sensitive and specific detection of all strains of Influenza A virus RNA, including novel clinical isolates. Includes primer mix, positive control vector for copy number quantification, and nuclease-free water as negative control. 100 reactions per kit.
• Detect Pro Influenza B Real-Time PCR Detection Kit SYBR Green-based real-time RT-PCR kit for sensitive and specific detection of all strains of Influenza B virus RNA, including novel clinical isolates. Includes primer mix, positive control vector for copy number quantification, and nuclease-free water as negative control. 100 reactions per kit.
• Industrial Antiviral Testing Services

Quantifiable outcome

• Assay repeat guarantee: if experiments do not meet internal quality standards, assays are repeated at no additional cost

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature6 records

Partnerships

One partnership is on record.

• Advanced Virology Inc.coreStrategic or Co-development Partner · 1 October 2025Strategic partnership announced October 2025 combining VRS's specialized testing capabilities with Advanced Virology's engineered virus production. Together they offer an integrated solution for clients needing both engineered virus materials and validated testing services. This partnership enables VRS to offer more comprehensive solutions to their pharmaceutical and biotechnology clients.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: Global testing services group with a substantial life sciences and microbiology testing portfolio. Operates virology and antiviral testing capabilities across many geographies, but as part of a much broader service catalog.
• Charles River Laboratories: Large global CRO offering discovery, safety assessment and manufacturing services including microbiology and virology capabilities. Overlaps with VRS's preclinical virology services but is several orders of magnitude larger.
• SGS: Global testing, inspection and certification company with life sciences and consumer products testing services including antimicrobial and antiviral efficacy testing. Comparable in regulated industrial antiviral testing, much broader in scope.
• BioReliance (Merck Life Science Services): Merck's biosafety testing services business offering viral clearance, virus screening, and biosafety testing for biopharma. Overlaps with VRS's regulated antiviral testing but serves a broader bioprocess testing portfolio.
• New England Biolabs (NEB): Major reagent manufacturer whose qPCR/RT-qPCR master mixes are explicitly compatible with VRS's Detect Pro kits. Comparable as a competitor in the molecular diagnostics reagent space and a supplier ecosystem partner to VRS products.

Direct peers

• Microbiologics: Specialty provider of biological reference materials including viral and microbial strains for research, diagnostics and assay development. Comparable niche virology/microbiology product and services positioning.
• ImQuest BioSciences: US-based CRO focused on antiviral and antibacterial preclinical research services including drug screening, mechanism-of-action studies and resistance testing. Comparable service portfolio to VRS's antiviral drug screening and assay development offerings.
• Texcell: France-headquartered contract research organization providing viral clearance studies, biosafety testing and antiviral services. Direct comparable to VRS's industrial antiviral testing and virus-based assay offerings.
• hVIVO plc: UK-listed virology CRO specializing in human viral challenge studies and laboratory services for antiviral and vaccine development. Closest direct peer to VRS in terms of virology focus, UK base, and pharma/biotech customer base.
• Virapur: Viral products and services company offering virus propagation, purification, and viral-based assay services for research and biopharma. Comparable in being a specialized virology services provider serving pharma and academic customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/virresser
• LinkedInlinkedin.com/company/virologyresearchservices

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virology Research Services Ltd